Advertisement OmniComm signs multi-year agreement with top CROs for TrialOne - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

OmniComm signs multi-year agreement with top CROs for TrialOne

OmniComm Systems, a global provider of clinical data management solutions for clinical trials, has announced that one of the world's largest contract research organizations selected TrialOne to standardize processes, improve business intelligence, ensure regulatory compliance, and achieve overall business transformation across all of its global Phase I clinics.

TrialOne is a browser-based bedside data collection technology designed specifically to address the needs of Phase I clinics.

Subject recruitment, study data capture, sample tracking, reporting, data management and integration with laboratory and medical monitoring equipment are all inherent capabilities of TrialOne that led this CRO to select TrialOne.

Furthermore, TrialOne’s import and export features that provide integration with laboratory information management systems for lab orders and results processing is another significant feature that drove the selection.

TrialOne enables the automation of clinic data collection; standardizes recruiting; facilitates the collection of study data and sample tracking; reduces discrepancies inherent in paper-based applications; and ensures compliance.

"We are now seeing a major increase in activity in the Phase I clinic automation market and this latest major win for OmniComm confirms our position as the market leader," said Dr Kuno van der Post, senior vice president business development, OmniComm Systems.

"The continued adoption of TrialOne by the industry’s largest organizations is a testament to the high quality of our new technology."